Autoantibody profiles in the sera of European patients with myositis

Annals of the Rheumatic Diseases

Volumn 60, Issue 2, 2001, Pages 116-123

  Brouwer, R ^a   Hengstman, G J D ^a   Vree Egberts, W ^a   Ehrfeld, H ^b   Bozic, B ^c   Ghirardello, A ^d   Grondal G ^c   Hietarinta, M ^e   Isenberg, D ^f   Kalden, J R ^g   Lundberg, I ^c   Moutsopoulos, H ^h   Roux Lombard, P ⁱ   Vencovsky, J ^j   Wikman, A ^c   Seelig, H P ^b   Van Engelen, B G M ^a   Van Venrooij, W J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Institute of Immunology and Molecular Genetics   (Germany)

^c Institute of Immunology and Molecular Genetics ^*  (Sweden)

^d Division of Rheumatology   (Italy)

^e TURKU UNIVERSITY   (Finland)

^f Arthur Stanley House   (United Kingdom)

^g UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^h UNIVERSITY OF ATHENS   (Greece)

ⁱ UNIVERSITY OF GENEVA   (Switzerland)

^j INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ANTIBODY SCREENING; ANTIBODY SPECIFICITY; ARTICLE; CELL INCLUSION; DERMATOMYOSITIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; HUMAN; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MAJOR CLINICAL STUDY; MYOSITIS; POLYMYOSITIS; PRIORITY JOURNAL;

ANTIBODY SPECIFICITY; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; EUROPE; HUMANS; IMMUNOBLOTTING; MYOSITIS; PRECIPITIN TESTS;

EID: 0035132757     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.2.116     Document Type: Article

References (54)

1. Polymyositis, dermatomyositis and inclusion-body myositis
2. Sporadic inclusion-body myositis and hereditary inclusion-body myopathies: Current concepts of diagnosis and pathogenesis
3. Multiplicity of antibodies in myositis sera
4. Humoral immunity in polymyositis/dermatomyositis
5. A new approach to the classification of idiopathic inflammatory myopathy: Myositis-specific autoantibodies define useful homogeneous patient groups
6. Immune manifestations of inflammatory muscle disease
7. The yeast exosome and human PM-Scl are related complexes of 3′→5′ exonucleases
8. Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion
9. Knowing when not to stop: Selenocysteine incorporation in eukaryotes
10. The U1 snRNP complex: An autoantigen in connective tissue diseases. An update
11. Intracellular localization and nucleocytoplasmic transport of Ro RNP components
12. The major dermatomyositis-specific Mi-2 autoantigen is a presumed helicase involved in transcriptional activation
13. Myositis-associated antigens. Aminoacyl-tRNA synthetases Jo-1, PL-7, PL-12, EJ, and OJ
14. The autoantibody system: Anti-aminoacyl-tRNA synthetase antibodies
15. Anti-KS: Identification of autoantibodies to asparaginyl-transfer RNA synthetase associated with interstitial lung disease
16. Frequent occurrence of anti-tRNA(His) autoantibodies that recognize a conformational epitope in sera of patients with myositis
17. Autoantibodies against alanyl-tRNA synthetase and tRNAAla coexist and are associated with myositis
18. Structure and function of signal recognition particle (SRP)
19. Antibody to signal recognition particle in polymyositis
20. Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti-Jo-1 and anti-signal recognition particle autoantibodies
21. Molecular analysis of a major antigenic region of the 240-kD protein of Mi-2 autoantigen
22. Characterization of the CHD family of proteins
23. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
24. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation
25. Autoantibodies in the diagnosis of systemic rheumatic diseases
26. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide
27. Presence of the anti-Jo-1 autoantibody excludes inclusion body myositis
28. Autoantibodies to small nuclear and cytoplasmic ribonucleoproteins in Japanese patients with inflammatory muscle disease
29. Clinical, serologic, and immunogenetic features in Polish patients with idiopathic inflammatory myopathies
30. Distinctive features of idiopathic inflammatory myopathies in French Canadians
31. Adult onset polymyositis/dermatomyositis: Clinical and laboratory features and treatment response in 75 patients
32. A clinical, serological, and histopathological study of myositis patients with and without anti-RNP antibodies
33. Adult onset polymyositis/dermatomyositis: An analysis of clinical and laboratory features and survival in 76 patients with a review of the literature
34. Clinical and serologic features of patients with polymyositis or dermatomyositis
35. Dermatopolymyositis and other connective tissue diseases: A review of 105 cases
36. Prognostic factors in polymyositis/dermatomyositis. A computer-assisted analysis of ninety-two cases
37. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis
38. Anti-Ro52 antibodies frequently co-occur with anti-Jo-1 antibodies in sera from patients with idiopathic inflammatory myopathy
39. The relative prevalence of dermatomyositis and polymyositis in Europe exhibits a latitudinal gradient
40. Inclusion body myositis
41. Polymyositis and dermatomyositis (first of two parts)
42. Characterization of human autoantibodies that selectively precipitate the 7SL RNA component of the signal recognition particle
43. Significance of Mi-2 autoantibodies in polymyositis and dermatomyositis
44. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations
45. Cloning and characterization of the cDNA coding for a polymyositis-scleroderma overlap syndrome-related nucleolar 100-kD protein
46. Cloning of a complementary DNA coding for the 100-kD antigenic protein of the PM-Scl autoantigen
47. Molecular characterization of an autoantigen of PM-Scl in the polymyositis/scleroderma overlap syndrome: A unique and complete human cDNA encoding an apparent 75-kD acidic protein of the nucleolar complex
48. Analysis of the specificity of anti-PM-Scl autoantibodies
49. Immune aspects of myositis
50. Humoral immunity and immunogenetics in the idiopathic inflammatory myopathies
51. The association of anti-Ro52 autoantibodies with myositis and scleroderma autoantibodies
52. Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjogren's syndrome
53. The association between Mi-2 antibodies and dermatomyositis
54. Genetics of the idiopathic inflammatory myopathies